PMDA drug package insert
トルバプタンOD錠7.5mg「トーワ」
PMDA Prescription drug · 東和薬品株式会社 · package insert Aug 17, 2026
Key facts
| Brand names | トルバプタンOD錠7.5mg「トーワ」, トルバプタンOD錠15mg「トーワ」, トルバプタンOD錠30mg「トーワ」, トルバプタン顆粒1%「トーワ」 |
|---|---|
| Nonproprietary names | トルバプタン |
| Companies | 製造販売元／東和薬品株式会社 |
| Product type | Prescription drug |
| Therapeutic category | V2-受容体拮抗剤 |
| Therapeutic category codes | 87213987249 |
| YJ codes | 2139011F3093, 2139011F4081, 24990A2F1049, 2139011D1030 |
| Approval numbers | 30400AMX00331, 30400AMX00332, 30800AMX00241, 30400AMX00152 |
| Package insert edition | 第6版 |
| Package insert date | Aug 17, 2026 |
| PMDA document key | 480235_2139011D1030_1 |
| PMDA company code | 480235 |
At a glance
- 1–9 Package insert revisions
- 10–99 Related PMDA documents
- None Safety communications
- No PMDA review report published
- Yes Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: